20-Hydroxyeicosatetraenoic Acid is a Potential Therapeutic Target in Cardiovascular Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|14|6|706-719

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.14, Iss.6, 2013-07, pp. : 706-719

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges

By Hu Erding   Lee Dennis  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 715-736

Informa Healthcare

Access to resources Recommend Favorite

CYP4 Enzymes As Potential Drug Targets: Focus on Enzyme Multiplicity, Inducers and Inhibitors, and Therapeutic Modulation of 20- Hydroxyeicosatetraenoic Acid (20-HETE) Synthase and Fatty Acid ω- Hydroxylase Activities

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 12, 2013-06 ,pp. : 1429-1440

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka   Shimokawa Hiroaki  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases

By  

Current Drug Targets, Vol. 13, Iss. 9, 2012-08 ,pp. : 1215-1221

Bentham Science Publishers

Access to resources Recommend Favorite

TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases

By  

Current Drug Targets, Vol. 13, Iss. 8, 2012-07 ,pp. : 1089-1095

Bentham Science Publishers

Access to resources Recommend Favorite